MiR-141-3p acts as a tumor-suppressor gene in colorectal cancer and enhances the sensitivity of colorectal cancer cells to cetuximab by inhibiting EGFR (Xing et al., 2020). This evidence concerns the gene EGFR and colorectal cancer.